EFFICACY OF SUBCUTANEOUS HOMOHARRINGTONINE IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT TO TYROSINE KINASE INHIBITORS (TKI) AND HARBORING A BCR-ABL MUTATION

被引：0
|
作者：
Marin, D. [1 ]
Maloisel, F. [3 ]
Legros, L. [2 ]
Nicolini, F. E. [4 ]
Roy, L. [5 ]
Rousselot, P. [6 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] CHU Hop Archet, Nice, France
[3] CHU Hosp Civil, Strasbourg, France
[4] CHU Hop Edouard Herriot, Lyon, France
[5] CHU Hop Jean Bernard, Poitiers, France
[6] Hop Andre Mignot, Le Chesnay, France
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O139
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [41] Mutational analysis of tyrosine kinase domain of BCR-ABL1 gene in chronic myeloid leukemia patients resistant to tyrosine kinase inhibitors
    Kihel, I.
    Nachi, M.
    Cayuela, J.
    Bekadja, M. A.
    Note, A.
    CLINICA CHIMICA ACTA, 2024, 558
  • [42] Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)
    Aviles-Vazquez, Socrates
    Chavez-Gonzalez, Antonieta
    Mayani, Hector
    GACETA MEDICA DE MEXICO, 2013, 149 (06): : 646 - 654
  • [43] THE RATE OF BCR-ABL DECLINE AS AN OPTIMIZED PREDICTOR OF OUTCOME FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE ON TREATMENT WITH TYROSINE KINASE INHIBITORS
    Fominykh, M.
    Shuvaev, V.
    Martynkevich, I.
    Tsaur, G.
    Bederak, N.
    Chelysheva, E.
    Shukhov, O.
    Abdullaev, A.
    Udaleva, V.
    Golovchenko, R.
    Zotova, I.
    Shikhbabaeva, D.
    Polushkina, L.
    Petrova, E.
    Ivanova, M.
    Martynenko, L.
    Kleina, E.
    Cybakova, N.
    Turkina, A.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2015, 100 : 444 - 444
  • [44] LONG TERM RESULTS WITH TYROSINE KINASE INHIBITORS BCR-ABL IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE
    Nunnz Yizel, Paz
    Gabriela, Silva Carreras F.
    Victoria, Vaitsekhovich
    Cecile, Mba
    Navascues Javier, Cornago
    Juan Luis, Steegmann Olmedillas
    HAEMATOLOGICA, 2016, 101 : 176 - 176
  • [45] Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib
    Tsaur, Grigory
    Ivanova, Anna
    Popov, Alexander
    Yakovleva, Yulia
    Riger, Tatyana
    Plekhanova, Olga
    Ivanets, Yulia
    Misyurin, Andrey
    Suchkova, Marina
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    BLOOD, 2010, 116 (21) : 1402 - 1402
  • [46] ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Ernst, Thomas
    Hoffmann, Jana
    Erben, Philipp
    Hanfstein, Benjamin
    Leitner, Armin
    Hehlmann, Ruediger
    Hochhaus, Andreas
    Mueller, Martin C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (09): : 1389 - 1393
  • [47] Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia
    Radich, Jerald P.
    CANCER, 2012, 118 (02) : 300 - 311
  • [48] ASSESSMENT OF THE RESULT OF BCR-ABL MUTATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS
    Demircioglu, S.
    Balasar, M.
    Yildirim, M.
    LEUKEMIA RESEARCH, 2016, 49 : S40 - S40
  • [49] BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
    Soverini, Simona
    Hochhaus, Andreas
    Nicolini, Franck E.
    Gruber, Franz
    Lange, Thoralf
    Saglio, Giuseppe
    Pane, Fabrizio
    Mueller, Martin C.
    Ernst, Thomas
    Rosti, Gianantonio
    Porkka, Kimmo
    Baccarani, Michele
    Cross, Nicholas C. P.
    Martinelli, Giovanni
    BLOOD, 2011, 118 (05) : 1208 - 1215
  • [50] A Five-Year Follow-up on Safety and Efficacy of Olverembatinib (HQP1351), a Novel Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) in China
    Jiang, Qian
    Li, Zongru
    Qin, Ya-Zhen
    Zhao, Ting
    Liu, Bingcheng
    Chen, Zi
    Niu, Qian
    Men, Lichuang
    Wang, Hengbang
    Yang, Dajun
    Zhai, Yifan
    Huang, Xiao-Jun
    BLOOD, 2022, 140
12345